Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

Blog

Daily evidence-led peptide research, regulatory news, expert digest and explainers. Every claim sourced; no AI tells.

Page 16

Trial readouts

GLP-1 Drugs for Antipsychotic Weight Gain

A 2026 meta-analysis found GLP-1 drugs reduced antipsychotic-related weight and metabolic measures, with more gastrointestinal side effects.

25 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

GLP-1 Drugs and Bone Density Review

A 2026 review found GLP-1 bone evidence too sparse for a class verdict, while small semaglutide and liraglutide trials raised questions.

25 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

GLP-1 Facial Changes: What Data Show

A 2026 review links GLP-1-associated facial hollowing mainly to weight loss, while drug-specific effects and prevention remain uncertain.

25 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Are GLP-1 Trials Measuring Nausea Well?

A 2026 review finds that major GLP-1 obesity trials recorded nausea without a validated, symptom-specific patient questionnaire.

25 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Expert digest

No Trial Defines the KLOW Plus CJC Stack

No clinical trial defines dosing or timing for a KLOW, CJC-1295, and ipamorelin stack, and the component evidence cannot create a protocol.

25 Oct 2026 · PeptideMethods Editorial Team · 5 min read
Trial readouts

Semaglutide and Adipose Inflammation

A 2026 mouse study found semaglutide briefly suppressed visceral-fat inflammation before weight regain reversed the tissue changes.

25 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Expert digest

Tesamorelin or CJC/Ipamorelin?

Tesamorelin, CJC-1295, and ipamorelin affect the growth-hormone axis, but no head-to-head evidence supports switching or cycling among them.

25 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

BPC-157 Fusion Proteins: Rat Readout

A 2026 BPC-157 study tested two bacteria-made fusion proteins in a rat stomach-ulcer model, not ordinary BPC-157 in people.

24 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Butyrate and Semaglutide in Obese Mice

Butyrate increased semaglutide's body-weight effect in obese mice, but the study provides no evidence of added efficacy in people.

24 Oct 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

CJC-1295 Dosing in Human Studies

Human CJC-1295 studies report dose levels for short hormone-response experiments, not an approved dose or a self-use protocol.

24 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

GLP-1 Cardiovascular Trials: 2026 Review

A 2026 review links five major cardiovascular, kidney and heart-failure trials, but each result belongs to a specific drug, population and endpoint.

24 Oct 2026 · PeptideMethods Editorial Team · 4 min read
Trial readouts

Gut-Brain Axis in Alzheimer's

A 2026 review maps gut-immune pathways in Alzheimer's disease but reports no new patient outcomes and no proven microbiome treatment.

24 Oct 2026 · PeptideMethods Editorial Team · 5 min read